Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic ...

The SunRISe-2 study, in people with muscle-invasive bladder cancer (MIBC ... it it is being used to deliver the chemotherapy agent gemcitabine. In a statement, J&J said that the trial – which ...

A Prescription Drug User Fee Act target action date of June 13, 2025, has been set for the new drug application of intravesical mitomycin.

[32] CR was achieved in 78.8% of cases after the initial radiochemotherapy using gemcitabine and cisplatin ... Trimodality treatment for bladder cancer in its various forms is becoming a standard ...

While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...

In this Review I present an overview of the management of nonmuscle invasive bladder cancer. The most common intravesical chemotherapeutic agents are described as well as the impact of ...

In 2016, about 18,000 women will be told they have bladder cancer. Your bladder is an organ in your pelvic area that holds urine. Most bladder cancers start in the cells that line the inside of the ...